RU2681544C2 - Локальные антибиотические композиции - Google Patents
Локальные антибиотические композиции Download PDFInfo
- Publication number
- RU2681544C2 RU2681544C2 RU2016134417A RU2016134417A RU2681544C2 RU 2681544 C2 RU2681544 C2 RU 2681544C2 RU 2016134417 A RU2016134417 A RU 2016134417A RU 2016134417 A RU2016134417 A RU 2016134417A RU 2681544 C2 RU2681544 C2 RU 2681544C2
- Authority
- RU
- Russia
- Prior art keywords
- silver
- composition
- carboxylate
- specified
- composition according
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 191
- 230000003115 biocidal effect Effects 0.000 title abstract description 20
- 238000009472 formulation Methods 0.000 title abstract description 5
- 230000000699 topical effect Effects 0.000 title description 3
- 229910052709 silver Inorganic materials 0.000 claims abstract description 120
- 239000004332 silver Substances 0.000 claims abstract description 116
- -1 aliphatic silver carboxylate Chemical class 0.000 claims abstract description 95
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims abstract description 70
- 150000001875 compounds Chemical class 0.000 claims abstract description 30
- 239000004599 antimicrobial Substances 0.000 claims abstract description 13
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 claims description 34
- 229910052799 carbon Inorganic materials 0.000 claims description 26
- 150000007942 carboxylates Chemical class 0.000 claims description 26
- 229910001923 silver oxide Inorganic materials 0.000 claims description 18
- 230000000845 anti-microbial effect Effects 0.000 claims description 17
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 14
- 239000002674 ointment Substances 0.000 claims description 12
- 239000000839 emulsion Substances 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 9
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 8
- 239000000194 fatty acid Substances 0.000 claims description 8
- 229930195729 fatty acid Natural products 0.000 claims description 8
- 150000004665 fatty acids Chemical class 0.000 claims description 8
- 125000001183 hydrocarbyl group Chemical group 0.000 claims description 8
- 150000001735 carboxylic acids Chemical class 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000012545 processing Methods 0.000 claims description 4
- KWVVTSALYXIJSS-UHFFFAOYSA-L silver(ii) fluoride Chemical compound [F-].[F-].[Ag+2] KWVVTSALYXIJSS-UHFFFAOYSA-L 0.000 claims description 4
- 230000002087 whitening effect Effects 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- ARXVTYGOLNYKET-UHFFFAOYSA-L pyridine-2-carboxylate;silver Chemical compound [Ag].[O-]C(=O)C1=CC=CC=N1.[O-]C(=O)C1=CC=CC=N1 ARXVTYGOLNYKET-UHFFFAOYSA-L 0.000 claims description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 claims description 2
- 239000000126 substance Substances 0.000 abstract description 16
- 239000003242 anti bacterial agent Substances 0.000 abstract description 8
- 244000005700 microbiome Species 0.000 abstract description 6
- 239000003814 drug Substances 0.000 abstract description 3
- 210000005260 human cell Anatomy 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 description 28
- 239000012166 beeswax Substances 0.000 description 26
- 238000006243 chemical reaction Methods 0.000 description 26
- 239000011541 reaction mixture Substances 0.000 description 26
- 235000013871 bee wax Nutrition 0.000 description 25
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 19
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 18
- 238000005259 measurement Methods 0.000 description 17
- 229940119170 jojoba wax Drugs 0.000 description 16
- 210000004027 cell Anatomy 0.000 description 13
- ANQVKHGDALCPFZ-UHFFFAOYSA-N ethyl 2-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]acetate Chemical compound C1=C2NC(CC(=O)OCC)=NC2=CC=C1N1CCN(C)CC1 ANQVKHGDALCPFZ-UHFFFAOYSA-N 0.000 description 13
- 239000007788 liquid Substances 0.000 description 12
- 230000000844 anti-bacterial effect Effects 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- YBAGJXAHJCEPHD-UHFFFAOYSA-L C(CCCCCCCCCCCCCCC)(=O)[O-].[Ag+2].C(CCCCCCCCCCCCCCC)(=O)[O-] Chemical compound C(CCCCCCCCCCCCCCC)(=O)[O-].[Ag+2].C(CCCCCCCCCCCCCCC)(=O)[O-] YBAGJXAHJCEPHD-UHFFFAOYSA-L 0.000 description 9
- 235000021314 Palmitic acid Nutrition 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 238000001362 electron spin resonance spectrum Methods 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 8
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- OBKXEAXTFZPCHS-UHFFFAOYSA-N 4-phenylbutyric acid Chemical compound OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 description 7
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 239000000440 bentonite Substances 0.000 description 6
- 229910000278 bentonite Inorganic materials 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 230000005855 radiation Effects 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 238000001228 spectrum Methods 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- XUZMHUZZZREUHQ-UHFFFAOYSA-L C(CCCCCCCCCCCCCCCCCCCCC)(=O)[O-].C(CCCCCCCCCCCCCCCCCCCCC)(=O)[O-].[Ag+2] Chemical compound C(CCCCCCCCCCCCCCCCCCCCC)(=O)[O-].C(CCCCCCCCCCCCCCCCCCCCC)(=O)[O-].[Ag+2] XUZMHUZZZREUHQ-UHFFFAOYSA-L 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 5
- 241000233866 Fungi Species 0.000 description 5
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 5
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000001993 wax Substances 0.000 description 5
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 235000021357 Behenic acid Nutrition 0.000 description 4
- CKDZHTMVLSSICW-UHFFFAOYSA-L C(CCCCCCCCCCCCCCCCC)(=O)[O-].C(CCCCCCCCCCCCCCCCC)(=O)[O-].[Ag+2] Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)[O-].C(CCCCCCCCCCCCCCCCC)(=O)[O-].[Ag+2] CKDZHTMVLSSICW-UHFFFAOYSA-L 0.000 description 4
- 239000004264 Petrolatum Substances 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 4
- 229940116226 behenic acid Drugs 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 229940066842 petrolatum Drugs 0.000 description 4
- 235000019271 petrolatum Nutrition 0.000 description 4
- SIOXPEMLGUPBBT-UHFFFAOYSA-M picolinate Chemical compound [O-]C(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-M 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000002310 reflectometry Methods 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- LTYHQUJGIQUHMS-UHFFFAOYSA-M silver;hexadecanoate Chemical compound [Ag+].CCCCCCCCCCCCCCCC([O-])=O LTYHQUJGIQUHMS-UHFFFAOYSA-M 0.000 description 4
- 230000035899 viability Effects 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 241000222122 Candida albicans Species 0.000 description 3
- 206010011985 Decubitus ulcer Diseases 0.000 description 3
- 208000004210 Pressure Ulcer Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 229940095731 candida albicans Drugs 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000007717 exclusion Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 239000000395 magnesium oxide Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 229950009215 phenylbutanoic acid Drugs 0.000 description 3
- VFWRGKJLLYDFBY-UHFFFAOYSA-N silver;hydrate Chemical compound O.[Ag].[Ag] VFWRGKJLLYDFBY-UHFFFAOYSA-N 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 206010072170 Skin wound Diseases 0.000 description 2
- 229910010413 TiO 2 Inorganic materials 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000001632 homeopathic effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 238000009616 inductively coupled plasma Methods 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- AQRYNYUOKMNDDV-UHFFFAOYSA-M silver behenate Chemical compound [Ag+].CCCCCCCCCCCCCCCCCCCCCC([O-])=O AQRYNYUOKMNDDV-UHFFFAOYSA-M 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- OBKXEAXTFZPCHS-UHFFFAOYSA-M 4-phenylbutyrate Chemical compound [O-]C(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-M 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 1
- LPNSPGXKLAGVAY-UHFFFAOYSA-L C(CCCCCCCCCCC)(=O)[O-].[Ag+2].C(CCCCCCCCCCC)(=O)[O-] Chemical compound C(CCCCCCCCCCC)(=O)[O-].[Ag+2].C(CCCCCCCCCCC)(=O)[O-] LPNSPGXKLAGVAY-UHFFFAOYSA-L 0.000 description 1
- TUVVHZPYIBXONN-UHFFFAOYSA-L C1(=CC=CC=C1)CCCC(=O)[O-].[Ag+2].C1(=CC=CC=C1)CCCC(=O)[O-] Chemical compound C1(=CC=CC=C1)CCCC(=O)[O-].[Ag+2].C1(=CC=CC=C1)CCCC(=O)[O-] TUVVHZPYIBXONN-UHFFFAOYSA-L 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 238000004435 EPR spectroscopy Methods 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000218636 Thuja Species 0.000 description 1
- 240000003243 Thuja occidentalis Species 0.000 description 1
- 235000008109 Thuja occidentalis Nutrition 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 150000001559 benzoic acids Chemical class 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000008387 emulsifying waxe Substances 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000002354 inductively-coupled plasma atomic emission spectroscopy Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002576 ketones Chemical group 0.000 description 1
- 210000001985 kidney epithelial cell Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- OTCVAHKKMMUFAY-UHFFFAOYSA-N oxosilver Chemical class [Ag]=O OTCVAHKKMMUFAY-UHFFFAOYSA-N 0.000 description 1
- 208000003154 papilloma Diseases 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- KZJPVUDYAMEDRM-UHFFFAOYSA-M silver;2,2,2-trifluoroacetate Chemical compound [Ag+].[O-]C(=O)C(F)(F)F KZJPVUDYAMEDRM-UHFFFAOYSA-M 0.000 description 1
- ORYURPRSXLUCSS-UHFFFAOYSA-M silver;octadecanoate Chemical compound [Ag+].CCCCCCCCCCCCCCCCCC([O-])=O ORYURPRSXLUCSS-UHFFFAOYSA-M 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 238000005979 thermal decomposition reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461931944P | 2014-01-27 | 2014-01-27 | |
| US61/931,944 | 2014-01-27 | ||
| PCT/IB2015/050630 WO2015111032A1 (en) | 2014-01-27 | 2015-01-27 | Topical antibiotic formulations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| RU2016134417A RU2016134417A (ru) | 2018-03-01 |
| RU2016134417A3 RU2016134417A3 (enExample) | 2018-09-20 |
| RU2681544C2 true RU2681544C2 (ru) | 2019-03-11 |
Family
ID=53680912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016134417A RU2681544C2 (ru) | 2014-01-27 | 2015-01-27 | Локальные антибиотические композиции |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9901541B2 (enExample) |
| EP (1) | EP3099310B1 (enExample) |
| JP (1) | JP6622218B2 (enExample) |
| KR (1) | KR102292758B1 (enExample) |
| CN (1) | CN106211756B (enExample) |
| AU (1) | AU2015208739B2 (enExample) |
| CA (1) | CA2974179C (enExample) |
| IL (1) | IL246981B (enExample) |
| MX (1) | MX383014B (enExample) |
| RU (1) | RU2681544C2 (enExample) |
| WO (1) | WO2015111032A1 (enExample) |
| ZA (1) | ZA201605935B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10376541B2 (en) * | 2014-01-27 | 2019-08-13 | Aidance Skincare & Topical Solutions Llc | Topical antibiotic formulations |
| ES2979247T3 (es) * | 2017-04-07 | 2024-09-25 | Univ Western Australia | Un método para ensayar la sensibilidad a los antimicrobianos |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0255248A2 (en) * | 1986-07-24 | 1988-02-03 | Minnesota Mining And Manufacturing Company | Antimicrobial wound dressing |
| US20050069502A1 (en) * | 2003-08-15 | 2005-03-31 | Chopra Suman K. | Hydrophobic polymer carrier based liquid tooth whitening composition |
| GB2472126A (en) * | 2009-07-21 | 2011-01-26 | Aidance Skincare & Topical Solutions Llc | Topical formulation comprising zinc oxide and silver (II) oxide |
| RU2448711C2 (ru) * | 2006-11-10 | 2012-04-27 | Дзе Проктер Энд Гэмбл Компани | Композиции для ухода за полостью рта, содержащие комбинации антибактериальных агентов и агентов, изменяющих реакцию организма-носителя |
| WO2013001172A1 (en) * | 2011-06-30 | 2013-01-03 | Silverphase Oy | Polymeric antimicrobial additive |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03141205A (ja) * | 1989-10-24 | 1991-06-17 | Ajinomoto Co Inc | 抗菌剤 |
| US20020127282A1 (en) * | 1991-12-05 | 2002-09-12 | N. Jonas & Co., Inc. A/K/A N. Jonas & Co. | Multivalent silver pharmaceuticals |
| US5491059A (en) * | 1994-10-31 | 1996-02-13 | Minnesota Mining And Manufacturing Company | Silver carboxylate compounds as silver sources in photothermographic and thermographic elements |
| JPH0967231A (ja) * | 1995-09-01 | 1997-03-11 | Nikko Kemikaruzu Kk | 脂肪酸銀を含有する抗菌剤組成物及び該脂肪酸銀を含有する化粧品 |
| NZ512267A (en) * | 1998-11-09 | 2003-11-28 | Ira Jay Newman | Ionic silver complex |
| US7001617B2 (en) * | 2001-04-23 | 2006-02-21 | Nueryst Pharmaceuticals Corp. | Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals |
| JP4303915B2 (ja) * | 2002-05-31 | 2009-07-29 | 山口 康子 | 抗菌性組成物及びその製造方法 |
| CN102783499A (zh) * | 2004-07-30 | 2012-11-21 | 金伯利-克拉克环球有限公司 | 抗微生物的装置和组合物 |
| CN101336640A (zh) | 2008-08-29 | 2009-01-07 | 宜兴市乔阳电器有限公司 | 四氧化四银杀菌剂、制备方法及其应用 |
-
2015
- 2015-01-27 KR KR1020167023448A patent/KR102292758B1/ko active Active
- 2015-01-27 EP EP15740451.8A patent/EP3099310B1/en active Active
- 2015-01-27 WO PCT/IB2015/050630 patent/WO2015111032A1/en not_active Ceased
- 2015-01-27 CN CN201580016290.1A patent/CN106211756B/zh active Active
- 2015-01-27 RU RU2016134417A patent/RU2681544C2/ru active
- 2015-01-27 JP JP2016565585A patent/JP6622218B2/ja active Active
- 2015-01-27 CA CA2974179A patent/CA2974179C/en active Active
- 2015-01-27 MX MX2016009696A patent/MX383014B/es unknown
- 2015-01-27 AU AU2015208739A patent/AU2015208739B2/en active Active
-
2016
- 2016-03-09 US US15/064,623 patent/US9901541B2/en active Active
- 2016-07-27 IL IL246981A patent/IL246981B/en active IP Right Grant
- 2016-08-25 ZA ZA2016/05935A patent/ZA201605935B/en unknown
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0255248A2 (en) * | 1986-07-24 | 1988-02-03 | Minnesota Mining And Manufacturing Company | Antimicrobial wound dressing |
| US20050069502A1 (en) * | 2003-08-15 | 2005-03-31 | Chopra Suman K. | Hydrophobic polymer carrier based liquid tooth whitening composition |
| RU2448711C2 (ru) * | 2006-11-10 | 2012-04-27 | Дзе Проктер Энд Гэмбл Компани | Композиции для ухода за полостью рта, содержащие комбинации антибактериальных агентов и агентов, изменяющих реакцию организма-носителя |
| GB2472126A (en) * | 2009-07-21 | 2011-01-26 | Aidance Skincare & Topical Solutions Llc | Topical formulation comprising zinc oxide and silver (II) oxide |
| WO2013001172A1 (en) * | 2011-06-30 | 2013-01-03 | Silverphase Oy | Polymeric antimicrobial additive |
Non-Patent Citations (3)
| Title |
|---|
| A.S. Kazachenko et al. SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF SILVER COMPLEXES WITH H * |
| A.S. Kazachenko et al. SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF SILVER COMPLEXES WITH HISTIDINE AND TRYPTOPHAN, 25.10.1999 * |
| A.S. Kazachenko et al. SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF SILVER COMPLEXES WITH HISTIDINE AND TRYPTOPHAN, 25.10.1999. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2974179C (en) | 2022-06-21 |
| US9901541B2 (en) | 2018-02-27 |
| EP3099310A4 (en) | 2017-07-26 |
| CA2974179A1 (en) | 2015-07-30 |
| MX383014B (es) | 2025-03-12 |
| WO2015111032A1 (en) | 2015-07-30 |
| AU2015208739A1 (en) | 2016-08-25 |
| CN106211756A (zh) | 2016-12-07 |
| KR20160112004A (ko) | 2016-09-27 |
| IL246981A0 (en) | 2016-09-29 |
| JP2017503864A (ja) | 2017-02-02 |
| KR102292758B1 (ko) | 2021-08-24 |
| EP3099310B1 (en) | 2025-10-01 |
| CN106211756B (zh) | 2019-12-27 |
| US20160184221A1 (en) | 2016-06-30 |
| RU2016134417A3 (enExample) | 2018-09-20 |
| ZA201605935B (en) | 2017-11-29 |
| IL246981B (en) | 2021-02-28 |
| MX2016009696A (es) | 2017-03-27 |
| JP6622218B2 (ja) | 2019-12-18 |
| AU2015208739B2 (en) | 2020-04-16 |
| RU2016134417A (ru) | 2018-03-01 |
| EP3099310A1 (en) | 2016-12-07 |
| EP3099310C0 (en) | 2025-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Korkmaz et al. | Biogenic silver nanoparticles synthesized via Mimusops elengi fruit extract, a study on antibiofilm, antibacterial, and anticancer activities | |
| Rajendran et al. | Photocatalytic, antibacterial and anticancer activity of silver-doped zinc oxide nanoparticles | |
| Ouyang et al. | A black phosphorus based synergistic antibacterial platform against drug resistant bacteria | |
| US10172361B2 (en) | Doped metal oxide nanoparticles of and uses thereof | |
| Rauf et al. | Biomimetically synthesized ZnO nanoparticles attain potent antibacterial activity against less susceptible S. aureus skin infection in experimental animals | |
| Malaikozhundan et al. | Two potential uses for silver nanoparticles coated with Solanum nigrum unripe fruit extract: biofilm inhibition and photodegradation of dye effluent | |
| Pandey et al. | Biocompatible gadolinium oxide nanoparticles as efficient agent against pathogenic bacteria | |
| Yan et al. | Preparation of graphene oxide/polydopamine-curcumin composite nanomaterials and its antibacterial effect against Staphylococcus aureus induced by white light | |
| Kumaraswamy et al. | Gamma irradiation synthesis and in vitro drug release studies of ZnO/PVA hydrogel nanocomposites | |
| Sathiyaseelan et al. | Biosynthesis of gallic acid fabricated tellurium nanoparticles (GA-Te NPs) for enhanced antibacterial, antioxidant, and cytotoxicity applications | |
| RU2681544C2 (ru) | Локальные антибиотические композиции | |
| Sudhakar et al. | Gelatin stabilized silver nanoparticles for wound healing applications | |
| Liu et al. | Facile synthesis of tannic acid modified NbTe2 nanosheets for effective photothermal ablation of bacterial pathogens | |
| Nagaiah et al. | In vitro evaluation of silver-zinc oxide-eugenol nanocomposite for enhanced antimicrobial and wound healing applications in diabetic conditions | |
| Bhosale et al. | Superior antibacterial performance of surfactant-assisted ZnO nanoflakes produced via Co-precipitation method | |
| Khamidov et al. | Thermal and biological properties of novel sodium carboxymethylcellulose-PPFMA nanocomposites containing biosynthesized Ag-ZnO hybrid filler | |
| Yazhiniprabha et al. | Biomimetically synthesized Physalis minima fruit extract-based zinc oxide nanoparticles as eco-friendly biomaterials for biological applications | |
| Darjee et al. | Scrupulous recognition of biologically important acids by fluorescent “turn off-on” mechanism of thaicalix reduced silver nanoparticles | |
| US11013763B2 (en) | Topical antibiotic formulations | |
| Thi et al. | Biogenic silver nanoparticles synthesized from Smilax glabra root extract: A green approach with antimicrobial properties | |
| Sharma et al. | Green synthesis of iron oxide nanoparticles and their efficacy against multi drug resistant bacteria and fungi | |
| Albratty et al. | Eco-Friendly Fabrication of SnO2-Curcumin Nanoparticles via Pterocarpus marsupium Extract: Unveiling Potent Antimicrobial and Anticancer Applications | |
| Qiao et al. | Solvent-dependent loading of curcumin on MXene for enhanced stability and photothermal/photodynamic antibacterial activity | |
| Ali et al. | Unveiling The Innovative Applications of Nano-binary Oxide ZnO/SiO2 Antibiotics Medical Ointment Apply on Wound Dressings | |
| Liang et al. | Ultrasound-activated piezo-catalysis in PDA-engineered barium titanate nanocomposites for oral healthcare |